# A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders

> **NCT02336243** · PHASE3 · UNKNOWN · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 2400 (estimated)

## Conditions studied

- Premature Birth
- Preeclampsia
- Fetal Growth Retardation
- Stillbirth

## Interventions

- **DIETARY_SUPPLEMENT:** Docosahexaenoic acid (DHA)
- **DIETARY_SUPPLEMENT:** Placebo (for Docosahexaenoic acid (DHA))

## Key facts

- **NCT ID:** NCT02336243
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2018-03
- **Final completion:** 2018-04
- **Target enrollment:** 2400 (ESTIMATED)
- **Last updated:** 2015-11-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02336243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02336243, "A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02336243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*